Cutaneous manifestations of endocrine diseases in children

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Endocrine diseases such as obesity, diabetes mellitus, Cushing’s syndrome, hypothyroidism and hyperthyroidism, acromegaly and hyperandrogenism in children and adolescents are often manifested by changes in the skin. Moreover, skin symptoms can be a marker of systemic, in this case, endocrine and metabolic diseases. Obesity and diabetes are chronic diseases that affect people all over the world, and their incidence is increasing in both children and adults. Clinically, they affect a number of organs, including the skin. The cutaneous manifestations caused or aggravated by obesity and diabetes are varied and usually bear some relation to the time that has elapsed since the onset of the disease. They include acrochordons, acanthosis nigricans, striae, xerosis, keratosis pilaris, plantar hyperkeratosis, fungal and bacterial skin infections, granuloma annulare, necrobiosis lipoidica. In obese patients, psoriasis and atopic dermatitis are more common than in the control group. With the pathology of the thyroid gland, diseases such as alopecia, pretibial myxedema, urticaria, and some others develop. Hyperandrogenism (polycystic ovary syndrome) is accompanied by skin lesions such as acne vulgaris, hirsutism, androgenic alopecia, acanthosis nigricans. This literature review focuses on the main skin syndromes accompanying endocrine pathology in children and adolescents. Information about such clinical associations can make it easier for pediatricians and endocrinologists to diagnose and treat endocrine diseases in a timely manner and, thereby, prevent long-term adverse consequences.

About the authors

Igor A. Gorlanov

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: Gorlanon53@mail.ru

MD, PhD, Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenerology

Russian Federation, Sаint Petersburg

Larisa M. Leina

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: larisa.leina@mail.ru

MD, PhD, Associate Professor, Department of Dermatovenerology

Russian Federation, Sаint Petersburg

Yulia L. Skorodok

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: julia_skorodok@mail.ru

MD, PhD, Associate Professor, Department of Pediatrics, Endocrinology and Abilitologii AF and DPO

Russian Federation, Sаint Petersburg

Irina R. Milyavskaya

St. Petersburg State Pediatric Medical University, Ministry of Healthcare of the Russian Federation

Email: imilyavskaya@yandex.ru

MD, PhD, Associate Professor, Department of Dermatovenerology

Russian Federation, Sаint Petersburg

References

  1. Абдулхабирова Ф.М., Абросимов А.Ю., Александрова Г.Ф., и др. Эндокринология: Российские клинические рекомендации. – М.: ГЭОТАР-Медиа, 2016. – 592 с. [Abdulhabirova FM, Abrosimov AJu, Aleksandrova GF, et al. Jendokrinologija: Rossijskie klinicheskie rekomendacii. Mosсow: GJeOTAR-Media, 2016. 592 p. (In Russ.)]
  2. Горланов И.А., Леина Л.М., Милявская И.Р., Заславский Д.В. Болезни кожи, ассоциированные с ожирением // Вестник дерматологии и венерологии. – 2016. – Т. 92. – № 6. – С. 20–26. [Gorlanov IA, Zaslavskiy DV, Leina LM, Milyavskaya IR. Obesity related skin disorders. Vestnik Dermatologii i Venerologii. 2016;92(6):20-26. (In Russ.)]
  3. Ковалева О.А., Амбросова Т.Н., Ащеулова Т.В. Адипокины: биологические, патофизиологические и метаболические эффекты // Внутренняя медицина. – 2009. – № 3. – С. 15–23. [Kovaleva OA, Ambrosova TN, Ashheulova TV. Adipokiny: biologicheskie, patofi-ziologicheskie i metabolicheskie jeffekty. The Russian Archives of Internal Medicine. 2009;(3): 15-23. (In Russ.)]
  4. Петренко Ю.В., Герасимова К.С., Новикова В.П. Биологическая и патофизиологическая значимость адипонектина // Педиатр. – 2019. – Т. 10. – № 2. С. – 83–87. [Petrenko YV, Gerasimova KS, Novikova VP. Biological and pathophysiological role of adiponectin. Pediatrician (St. Petersburg). 2019;10(2):83-87. (In Russ.)] https://doi.org/10.17816/PED10283-87
  5. Строев Ю.И., Чурилов Л.П. Эндокринология подростков. – СПб.: Медкнига «ЭЛБИ», 2004. – 384 с. [Stroev JuI, Churilov LP. Jendokrinologija podrostkov. Saint Petersburg: Medkniga “JeLBI”, 2004. 384 p. (In Russ.)]
  6. Шабалов Н.П., ред. Диагностика и лечение эндокринных заболеваний у детей и подростков: учебное пособие, 4-е изд. – М.: МЕДпресс-информ, 2018. [Shabalov NP, editor. Diagnostika i lechenie jendokrinnyh zabolevanij u detej i podrostkov: uchebnoe posobie, 4-e izd. M.: MEDpress-inform Publ., 2018. (In Russ.)]
  7. Шаповалова А.Б., Шершнёв А.А. Неаутоиммунные формы диабета у детей и подростков: новые ответы в вопросах факторов риска и диагностики // Медицина: теория и практика. – 2021. – Т. 6. – № 1. – С. 3–14. [Shapovalova AB, Shershnev AA. Non-autoimmune forms of diabetes in children and teens: new answers in questions of risk factors and diagnostics. Medicine: theory and practice. 2021;6(1):3-14. (In Russ.)]
  8. Angeli A, Boccuzzi G, Frajria R, Bisbocci D. Adrenal gland function test in the differential diagnosis of sthenic obesity with pink striae. Folia Endocrinol. 1970;23:566-578.
  9. Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema. Dermatology. 2015;231(1):35-40. https://doi.org/10.1159/000381913
  10. Baselga-Torres E, Torres-Pradilla M. Cutaneous manifestations in children with diabetes mellitus and obesity. Actas Dermosifiliogr. 2014;105(6):546-557. https://doi.org/10.1016/j.adengl.2014.05.016
  11. Birtane M, Tuna H. The evaluation of plantar pressure distribution in obese and non-obese adults. Clin Biomech. 2004;19(10):1055-1059. https://doi.org/10.1016/j.clinbiomech.2004.07.008
  12. Boza JC, Trindade EN, Peruzzo J, et al. Skin manifectations of obesity: a comparative study. J Eur Acad Dermatol Venereol. 2012;26(10):1220-1223. https://doi.org/10.1111/j.1468-3083.2011.04265.x
  13. Bremer S, Van Voorhess AS, Hsu S, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;63(6):1058-1069. https://doi.org/10.1016/j.jaad.2009.09.053
  14. Ceman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol. 2008;159(4):820-826. https://doi.org/10.1111/j.1365-2133.2008.08742.x
  15. Chen Y, Rennie D, Cormier Y, Dosman J. Association between obesity and atopy in adults. Int Arch Allergy Immunol. 2010;153(4):372-377. https://doi.org/10.1159/000316348
  16. Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portugese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol. 2010;24(12):1386-1394. https://doi.org/10.1111/j.1468-3083.2010.03647.x
  17. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911-920. https://doi.org/10.1016/j.jaci.2005.02.023
  18. Garcia-Hidalgo L, Orozco-Torete R, Gonzalez-Barranco J, et al. Dermatoses in 156 obese adults. Obes Res. 1999;7(3):299-302. https://doi.org/10.1002/ j.1550-8528.1999.tb00410.x
  19. Gerdes S, Rostami-Yazdi M, Mrowietz U. Adipokines and psoriasis. Exp Dermatol. 2011;20(2):81-87. https://doi.org/10.1111/j.1600-0625.2010.01210.x
  20. Guidolin L, Borin M, Fontana E, et al. Central Obesity in Children with Psoriasis. Acta Derm Venereol. 2018;98(2): 282-283. https://doi.org/10.2340/00015555-2816
  21. Hercogova J, Ricceri F, Tripo L, et al. Psoriasis and body mass index. Dermatol Ther. 2010;23(2):152-154. https://doi.org/10.1111/j.1529-8019.2010.01309.x
  22. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527-1534. https://doi.org/10.1001/archderm.141.12.1527
  23. Housman E, Reynolds RV. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations. J Am Acad Dermatol. 2014;71(5):847.e-858. https://doi.org/10.1016/j.jaad.2014.05.007
  24. Hsu HS, Chen W, Chen SC, Ko FD. Colored striae in obese children and adolescents. Zhonghua Min Guo. Xiao Er Ke Yi Xue Hui Za Zhi. 1996;37:349-352.
  25. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acantosis nigricans in an adult obese population. Arch Dermatol. 1992;128:941-944. https://doi.org/10.1001/archderm.128.7.941
  26. Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003;4:315-331. https://doi.org/10.2165/ 00128071-200304050-00003
  27. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159(2): 342-350. https://doi.org/10.1111/j.1365-2133.2008. 08655.x
  28. Keen MA, Shah IH, Sheikh G. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study. Indian Dermatol Online J. 2017;8(2):104-110. https://doi.org/10.4103/2229-5178.202275
  29. Koebnick C, Black MN, Smith N, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr. 2011;159(4): 577-583. https://doi.org/10.1016/j.jpeds.2011.03. 006
  30. Kordonouri O, Maguire AM, Knip M, et al. Other complications and associated conditions with diabetes in children and adolescents. Pediatr Diabetes. 2009;10(12):204-210. https://doi.org/10.1111/j. 1399-5448.2009.00573.x
  31. Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017;6(4):300-312. https://doi.org/10.21037/tp. 2017.09.08
  32. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172(6):298-304. https://doi.org/10.1159/000249365
  33. Loffler H, Aramaki JU, Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol. 2002;8(1):19-22. https://doi.org/10.1046/j.0909-752x
  34. Mahe E, MacCari F, Beauchet A, et al. Childhood-onset psoriasis: Association with future cardiovascular and metabolic comorbidities. Br J Dermatol. 2013;169(4): 889-895. https://doi.org/10.1111/bjd.12441
  35. Mahé E. Childhood psoriasis. Eur J Dermatol. 2016; 26(6):537-548. https://doi.org/10.1684/ejd.2016. 2932
  36. Mendes AL, Miot HA, Haddad V Jr. Diabetes mellitus and the skin. An Bras Dermatol. 2017;92(1):8-20. https://doi.org/10.1590/abd1806-4841.20175514
  37. Menne EN, Sonabend RY, Mason EO, et al. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect. 2012;65(2):135-141. https://doi.org/10.1016/j.jinf.2012.04.001
  38. Morgan AJ, Schwartz RA. Diabetic dermopathy: A subtle sign with grave implications. J Am Acad Dermatol. 2008;58(3):447-451. https://doi.org/10.1016/j.jaad.2007.11.013
  39. Murray CS, Canoy D, Buchan I, et al. Body mass index in young children and allergic disease: gender differences in a longitudinal study. Clin Experimental Allergy. 2010;41(1):78-85. https://doi.org/10.1111/j.1365-2222.2010.03598.x
  40. Nagel G, Koenig W, Rapp K, et al. Associations of adipokines with asthma, rhinoconjunctivitis, and eczema in German schoolchildren. Pediatr Allergy Immunol. 2009;20(1):81-88. https://doi.org/10.1111/j.1399-3038.2008.00740.x
  41. Ngo BT, Hayes KD, DiMiao DJ, et al. Manifestations of Cutaneous Diabetic Microangiopathy. Am J Clin Dermatol. 2005;6:225-237. https://doi.org/10.2165/00128071-200506040-00003
  42. Nino M, Franzese A, Ruggiero-Perrino N, Balato N. The effect of obesity on skin disease and epidermal permeability barrier status in children. Pediatr Dermatol. 2012;29(5):567-570. https://doi.org/10.1111/j.1525-1470.2012.01738.x
  43. Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149(2):166-176. https://doi.org/10.1001/jamadermatol.2013.1078
  44. Pavlović MD, Milenković T, Dinić M, et al. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care. 2007;30(8):1964-1967. https://doi.org/10.2337/dc07-0267
  45. Poeggeler B, Schulz C, Pappolla MA, et al. Leptin and the skin: a new frontier. Exp Dermatol. 2010;19(1):12-18. https://doi.org/10.1111/j.1600-0625.2009.00930.x
  46. Sakai R, Matsui S, Fukushima M, et al. Prognostic factor analysis for plaque psoriasis. Dermatology. 2005;211(2):103-106. doi: 10.1159/000086437
  47. Shipman AR, Millington GWM. Obesity and the skin. Br Dermatol. 2011:165(4):743-750. https://doi.org/10.1111/j.1365-2133.2011.10393.x
  48. Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: A case-control study. J Allergy Clin Immunol. 2011;127(5): 1180-1186. https://doi.org/10.1016/j.jaci.2011. 01.063
  49. Tobin A, Ahern T, Rogers S, et al. The dermatological consequences of obesity. Int J Dermatol. 2013;52(8):927-932. https://doi.org/10.1111/j.1365-4632.2012.05624.x
  50. Tollefson MM, Van Houten HK, Asante D, et al. Association of Psoriasis With Comorbidity Development in Children With Psoriasis. JAMA Dermatol. 2018;154(3): 286-292. doi: 10.1001/jamadermatol.2017.5417
  51. Torley D, Bellus GA, Munro CS. Genes growth factors and acantosis nigricans. Br J Dermatol. 2002;147(6):1096. doi: 10.1046/j.1365-2133.2002.05150.x
  52. Yosipovitch G, Mevorah B, Mashiach J, et al. High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris. Dermatology. 2000;201(1):34-36. doi: 10.1159/000018425
  53. Yosipovitch G, DeVore A, Dawn A. Obesity and skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901-916. doi: 10.1016/j.jaad.2006.12.004.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Acanthosis nigricans in an obese patient

Download (185KB)
3. Fig. 2. Striae in a 14-year-old obese girl

Download (159KB)
4. Fig. 3. Psoriasis in a 14-year-old obese girl

Download (352KB)

Copyright (c) 2021 Gorlanov I.A., Leina L.M., Skorodok Y.L., Milyavskaya I.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies